Related Experiment Video
Updated: Jun 21, 2026
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Comparative effectiveness research for antipsychotic medications: how much is enough?
David O Meltzer1, Anirban Basu, Herbert Y Meltzer
1University of Chicago, Chicago, Illinois, USA. dmeltzer@medicine.bsd.uchicago.edu
Health Affairs (Project Hope)
|July 23, 2009
Summary
Second-generation antipsychotics effectiveness requires more precise comparative research. Current data, including the CATIE study, may not fully support restricting coverage for these medications due to design and cost-analysis uncertainties.
Area of Science:
- Pharmacology
- Health Economics
- Clinical Trials
Background:
- Second-generation antipsychotics are widely used but face scrutiny regarding health effects and cost.
- The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study provided comparative data influencing policy decisions.
- Concerns exist regarding the CATIE study's design, cost-effectiveness analysis, and the precision of its findings.
Purpose of the Study:
- To evaluate the interpretation of comparative effectiveness data for second-generation antipsychotics.
- To address uncertainties in cost-effectiveness analyses and study designs.
- To determine the value of further research in comparing antipsychotic effectiveness.
Main Methods:
- Critical review of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study design.
- Analysis of cost-effectiveness data associated with second-generation antipsychotics.
- Assessment of the precision and reliability of existing comparative effectiveness findings.
Main Results:
- The interpretation of CATIE study findings to restrict coverage is questioned.
- Concerns about study design and cost-effectiveness analysis introduce uncertainty.
- Existing data may lack the necessary precision for definitive conclusions on antipsychotic effectiveness.
Conclusions:
- Further research is needed to enhance the precision of comparisons between antipsychotic medications.
- Additional studies are warranted to provide more robust evidence for policy-making.
- The cost of further research is justified by the potential for improved precision in effectiveness comparisons.
Related Concept Videos
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:22Dose-Response Relationship: Potency and Efficacy
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...